IRIS
SINAGRA, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.676
AS - Asia 3.294
EU - Europa 2.515
SA - Sud America 668
AF - Africa 97
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.460
SG - Singapore 1.174
IT - Italia 951
CN - Cina 833
RU - Federazione Russa 645
BR - Brasile 497
VN - Vietnam 465
BD - Bangladesh 255
DE - Germania 205
HK - Hong Kong 194
GB - Regno Unito 148
CA - Canada 127
FR - Francia 109
IE - Irlanda 76
IN - India 71
FI - Finlandia 70
AR - Argentina 69
NL - Olanda 63
PL - Polonia 56
MX - Messico 54
TR - Turchia 47
ZA - Sudafrica 46
PK - Pakistan 41
ID - Indonesia 38
ES - Italia 34
UA - Ucraina 34
SE - Svezia 32
JP - Giappone 31
EC - Ecuador 30
IQ - Iraq 30
CO - Colombia 28
AT - Austria 23
LT - Lituania 20
IL - Israele 18
VE - Venezuela 18
SA - Arabia Saudita 17
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 12
BE - Belgio 12
MA - Marocco 10
CL - Cile 9
EG - Egitto 9
KE - Kenya 9
CH - Svizzera 8
JM - Giamaica 8
MY - Malesia 8
TN - Tunisia 8
JO - Giordania 7
OM - Oman 7
SI - Slovenia 6
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
HN - Honduras 4
NZ - Nuova Zelanda 4
PA - Panama 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KR - Corea 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
CR - Costa Rica 2
CY - Cipro 2
GP - Guadalupe 2
GR - Grecia 2
HR - Croazia 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
RO - Romania 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
MN - Mongolia 1
NG - Nigeria 1
Totale 11.253
Salva come PNG Salva come JPEG
Città #
Dallas 1.830
Singapore 663
Ashburn 407
San Jose 403
Beijing 274
Hong Kong 186
Milan 174
Ho Chi Minh City 169
Los Angeles 128
New York 118
Moscow 104
Rome 98
Hanoi 87
Santa Clara 84
Council Bluffs 83
Dublin 76
Chandler 61
Munich 58
São Paulo 56
Orem 52
Lauterbourg 49
The Dalles 47
Warsaw 45
Hefei 44
Buffalo 42
Montreal 42
Helsinki 37
Frankfurt am Main 36
Johannesburg 34
Brooklyn 32
Boardman 31
Chennai 31
Columbus 30
San Mateo 30
Tokyo 29
Pisa 28
Denver 27
London 27
Mexico City 26
Bologna 25
Houston 25
Ottawa 25
Amsterdam 23
Naples 23
Beauharnois 22
Fairfield 22
Lappeenranta 22
Phoenix 22
Poplar 22
Seattle 22
Haiphong 21
Atlanta 20
Cambridge 20
Istanbul 19
Nuremberg 19
Turin 19
Boston 18
Chicago 18
Genoa 18
Da Nang 17
Florence 17
Portsmouth 17
Stockholm 16
West Jordan 16
Rio de Janeiro 15
San Francisco 15
Ankara 14
Brasília 14
Stevenage 14
Tashkent 14
Tel Aviv 14
Krefeld 13
Wilmington 13
Bari 12
Belo Horizonte 12
Biên Hòa 12
Padua 12
Querétaro 12
Guarulhos 11
Lahore 11
Lawrence 11
Manchester 11
Toronto 11
Turku 11
Verona 11
Washington 11
Bad Bellingen 10
Brussels 10
Dong Ket 10
Figino 10
Medellín 10
Ninh Bình 10
Paris 10
Porto Alegre 10
Buenos Aires 9
Jeddah 9
Nairobi 9
New Delhi 9
Shanghai 9
Shenzhen 9
Totale 6.694
Salva come PNG Salva come JPEG
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 729
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 480
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 431
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 339
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 324
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 292
[Ten perspectives for research and innovation in cardiac amyloidosis] 291
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 269
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 258
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 255
[Transcatheter devices for chronic heart failure: state of the art] 251
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 240
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 239
Valvular heart disease in patients with cardiac amyloidosis 235
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 234
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 230
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 227
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 225
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 225
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 221
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 220
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 217
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 215
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 214
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 212
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 211
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 208
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 207
The chronic heart failure evolutions: Different fates and routes 203
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 196
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 192
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 191
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 181
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 180
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 180
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 172
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 170
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 165
Change in prevalence of ATTR variants in Italy: results from a national survey 160
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 152
Cardiac amyloidosis: when to suspect and how to confirm 151
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 137
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 117
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 104
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis 79
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 75
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: The MECKI-RENAL study 68
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 66
Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC) 65
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study 59
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 58
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis 57
Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis 56
Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis 54
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis: The CAUSATIVE Study 50
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 48
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 46
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 44
Electrocardiographic abnormalities in patients with cardiomyopathies 36
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 36
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 35
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 30
null 26
High Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis in Older Adults with Carpal Tunnel Syndrome, Heart Failure or Increased Left Ventricular Mass: The CAPTURE Study 16
Diagnostic Role of Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations 11
Totale 11.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022174 19 25 2 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/20251.825 31 81 137 52 112 90 243 397 160 70 265 187
2025/20268.729 311 944 1.798 876 686 503 715 488 709 585 594 520
Totale 11.365